tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Summit Therapeutics: Ivonescimab OS Readout, Regulatory Milestones, and GSK Partnership Underpin Reaffirmed Buy and $40 Target
PremiumRatingsSummit Therapeutics: Ivonescimab OS Readout, Regulatory Milestones, and GSK Partnership Underpin Reaffirmed Buy and $40 Target
18d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
19d ago
Summit Therapeutics Expands Ivonescimab Program With GSK Collaboration
Premium
Company Announcements
Summit Therapeutics Expands Ivonescimab Program With GSK Collaboration
20d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
Short Report: Sezzle short interest at record high
Premium
The Fly
Short Report: Sezzle short interest at record high
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Akeso to announces results from OS analysis of Phase III HARMONi-A study
PremiumThe FlyAkeso to announces results from OS analysis of Phase III HARMONi-A study
3M ago
Insiders Are Snapping Up These 2 Stocks — and Analysts Like What They See
Premium
Stock Analysis & Ideas
Insiders Are Snapping Up These 2 Stocks — and Analysts Like What They See
3M ago
Summit Therapeutics files to sell 26.68M shares of common stock for holders
Premium
The Fly
Summit Therapeutics files to sell 26.68M shares of common stock for holders
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100